a study to evaluate the efficacy of different part of Shirisha plant in a semisolid dosage form (for e.g. like chyawanaprash) in the treatment of breathing problem (bronchial asthma)
Phase 2
- Conditions
- Health Condition 1: null- Tamaka Shwasa (Bronchial Asthama)
- Registration Number
- CTRI/2011/09/002010
- Lead Sponsor
- IPGT and RA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
1.Both the sexes having age between 16 years to 60 years
2.Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.
3.Symptoms/exacerbation (Wheeze, cough and breathlessness) more than once a week but less than once a day in frequency.
4.Night symptoms twice a month but less than once a week.
Exclusion Criteria
Age more than 60 years and below 16 years
Patients having anaemia, pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated conditions
Patients having diabetes, hypertension, Chronic and Acute renal failure etc. conditions in which urination is markedly diminished or excessive were excluded
HIV positive cases
Pregnant/lactating mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PEFR <br/ ><br>Respiration Rate <br/ ><br>Breath Holding Time <br/ ><br>Differential count of Neutrophils <br/ ><br>Leukocytes <br/ ><br>Absolute eosinophil count(AEC) <br/ ><br>Timepoint: after 28 days
- Secondary Outcome Measures
Name Time Method exacerbation of signs and symptoms of Bronchial AsthmaTimepoint: 15 days